RMNI(RMNI)
RMNI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $441M | $469M |
| Low | $435M | $463M |
| High | $445M | $473M |
| EBITDA Avg | $84M | $90M |
| Low | $83M | $89M |
| High | $85M | $91M |
| EBIT Avg | $86M | $91M |
| Low | $85M | $90M |
| High | $86M | $92M |
| Net Income Avg | $33M | $45M |
| Low | $32M | $44M |
| High | $34M | $46M |
| EPS Avg | $0.35 | $0.47 |
| Low | $0.34 | $0.46 |
| High | $0.36 | $0.48 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $111M | $118M | $112M | $113M | $117M | $125M |
| Low | $110M | $117M | $111M | $113M | $117M | $124M |
| High | $111M | $119M | $113M | $114M | $118M | $126M |
| EBITDA Avg | $21M | $23M | $21M | $22M | $22M | $24M |
| Low | $21M | $22M | $21M | $22M | $22M | $24M |
| High | $21M | $23M | $22M | $22M | $23M | $24M |
| EBIT Avg | $22M | $23M | $22M | $22M | $23M | $24M |
| Low | $21M | $23M | $22M | $22M | $23M | $24M |
| High | $22M | $23M | $22M | $22M | $23M | $24M |
| Net Income Avg | $10M | $15M | $7M | $9M | $12M | $16M |
| Low | $9M | $15M | $7M | $9M | $11M | $16M |
| High | $10M | $15M | $7M | $9M | $12M | $16M |
| EPS Avg | $0.11 | $0.16 | $0.08 | $0.10 | $0.12 | $0.17 |
| Low | $0.10 | $0.16 | $0.08 | $0.10 | $0.12 | $0.17 |
| High | $0.11 | $0.16 | $0.08 | $0.10 | $0.12 | $0.17 |
| Analysts (Rev / EPS) | 3 / 2 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |